BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2323089)

  • 21. Attitudes toward abortion among parents of children with cystic fibrosis.
    Wertz DC; Rosenfield JM; Janes SR; Erbe RW
    Am J Public Health; 1991 Aug; 81(8):992-6. PubMed ID: 1854017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Teaching about cystic fibrosis carrier screening by using written and video information.
    Clayton EW; Hannig VL; Pfotenhauer JP; Parker RA; Campbell PW; Phillips JA
    Am J Hum Genet; 1995 Jul; 57(1):171-81. PubMed ID: 7611285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population-based genetic screening for cystic fibrosis: attitudes and outcomes.
    Ioannou L; Massie J; Collins V; McClaren B; Delatycki MB
    Public Health Genomics; 2010; 13(7-8):449-56. PubMed ID: 20090299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population screening for cystic fibrosis: knowledge and emotional consequences 18 months later.
    Gordon C; Walpole I; Zubrick SR; Bower C
    Am J Med Genet A; 2003 Jul; 120A(2):199-208. PubMed ID: 12833400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient and parental attitudes toward genetic screening and its implications at an adult cystic fibrosis centre.
    Conway SP; Allenby K; Pond MN
    Clin Genet; 1994 Jun; 45(6):308-12. PubMed ID: 7923862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Family planning decisions after the birth of a cystic fibrosis child. The impact of prenatal diagnosis.
    Evers-Kiebooms G; Denayer L; Cassiman JJ; van den Berghe H
    Scand J Gastroenterol Suppl; 1988; 143():38-46. PubMed ID: 3164508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prenatal screening for cystic fibrosis carriers: does the method of testing affect the longer-term understanding and reproductive behaviour of women?
    Mennie ME; Axworthy D; Liston WA; Brock DJ
    Prenat Diagn; 1997 Sep; 17(9):853-60. PubMed ID: 9316130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attitudes Toward Discussing Approved and Investigational Treatments for Cystic Fibrosis in Prenatal Genetic Counseling Practice.
    Elsas CR; Schwind EL; Hercher L; Smith MJ; Young KG
    J Genet Couns; 2017 Feb; 26(1):63-71. PubMed ID: 27277131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prenatal genetic carrier testing using triple disease screening.
    Eng CM; Schechter C; Robinowitz J; Fulop G; Burgert T; Levy B; Zinberg R; Desnick RJ
    JAMA; 1997 Oct; 278(15):1268-72. PubMed ID: 9333269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utilization of prenatal diagnosis for cystic fibrosis over the past seven years.
    Jedlicka-Köhler I; Götz M; Eichler I
    Pediatrics; 1994 Jul; 94(1):13-6. PubMed ID: 8008524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Newborn bloodspot screening for cystic fibrosis: What do antenatal and postnatal women know about cystic fibrosis?
    Fitzgerald C; Linnane B; Heery E; Conneally N; George S; Fitzpatrick P
    J Cyst Fibros; 2016 Jul; 15(4):436-42. PubMed ID: 26708264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parental attitudes to the identification of their infants as carriers of cystic fibrosis by newborn screening.
    Lewis S; Curnow L; Ross M; Massie J
    J Paediatr Child Health; 2006 Sep; 42(9):533-7. PubMed ID: 16925540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The deletion F508 is the major gene mutation in a representative Belgian cystic fibrosis population.
    Bonduelle M; Lissens W; Malfroot A; Dab I; Liebaers I
    Hum Genet; 1990 Sep; 85(4):395-6. PubMed ID: 2210742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Newborn screening for cystic fibrosis - The parent perspective.
    Rueegg CS; Barben J; Hafen GM; Moeller A; Jurca M; Fingerhut R; Kuehni CE;
    J Cyst Fibros; 2016 Jul; 15(4):443-51. PubMed ID: 26751132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carrier screening for cystic fibrosis in a prenatal setting.
    Delvaux I; van Tongerloo A; Messiaen L; Van Loon C; De Bie S; Mortier G; De Paepe A
    Genet Test; 2001; 5(2):117-25. PubMed ID: 11551097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk perception after CF carrier testing and impact of the test result on reproductive decision making.
    Denayer L; Welkenhuysen M; Evers-Kiebooms G; Cassiman JJ; Van den Berghe H
    Am J Med Genet; 1997 Apr; 69(4):422-8. PubMed ID: 9098495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene therapy for cystic fibrosis: will it affect the uptake of prenatal carrier screening?
    Mennie ME; Compton ME; Liston WA; Brock DJ
    Prenat Diagn; 1994 Dec; 14(12):1158-62. PubMed ID: 7899283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of introducing prenatal diagnosis on the reproductive behaviour of families at risk for cystic fibrosis. A cohort study.
    Borgo G; Fabiano T; Perobelli S; Mastella G
    Prenat Diagn; 1992 Oct; 12(10):821-30. PubMed ID: 1475251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What do young people think about screening for cystic fibrosis?
    Cobb E; Holloway S; Elton R; Raeburn JA
    J Med Genet; 1991 May; 28(5):322-4. PubMed ID: 1865469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testing for cystic fibrosis using allelic association.
    Ivinson AJ; Read AP; Harris R; Super M; Schwarz M; Clayton Smith J; Elles R
    J Med Genet; 1989 Jul; 26(7):426-30. PubMed ID: 2746614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.